Investigation of biological readouts from studies of Poly (ADP-Ribose), Polymerase (PARP) inhibitors and Intraperitoneal chemotherapy as a driver towards individualisation of care in ovarian cancer

Project Details

StatusFinished
Effective start/end date1/11/1131/10/12

Funding

  • UK central government bodies/local authorities, health and hospital authorities: £93,750.00